Skip to main content
. 2020 Dec 14;11:557160. doi: 10.3389/fpsyt.2020.557160

Table 1.

Overview of demographics, psychopathology, available genotyping, and personality.

ADHD diagnosis
Healthy Patients
M No./SD M No./SD
Age 46.85 10.21 45.00 10.46
Gender Male 46 450
Female 47 453
Available genotyping (small sample)
Genotyped for PRS 453
Comorbid disorders
Depression 0 482
Anxiety 0 247
Alcohol Abuse 0 78
Addiction 0 79
Cannabis Abuse 0 93
Addiction 0 128
Sedatives Abuse 0 16
Addiction 0 15
Stimulants Abuse 0 53
Addiction 0 31
Opiates Abuse 0 22
Addiction 0 13
Cocaine Abuse 0 43
Addiction 0 19
Hallucinogens Abuse 0 42
Addiction 0 11
Personality questionnaires IV7 and NEO-5
Impulsivity 5.63 SD 3.03 10.40 SD 4.08
Venturesomeness 8.20 SD 3.25 8.10 SD 4.23
Empathy 10.71 2.63 10.99 2.83
Neuroticism 141.8 9.3 148.8 10.6
Extraversion 144.9 8.6 150.9 10.3
Openness 151.8 9.4 153.1 10.2
Agreeableness 151.2 9.8 154.2 10.8
Conscientiousness 151.4 9.9 153.7 10.5

Table 1 shows age and gender distribution in two columns for healthy controls and ADHD patients. It gives the number of genotyped patients, which forms our smaller sample used in separate analysis. It lists comorbid disorders. Grading between “abuse” and “addiction” was available for substance use disorders. The section on personality measures gives the mean for the IV7 and the NEO. No., number; M, mean; SD, standard deviation.